Moderna Inc. weekly uptrend opportunity based On 1.00 Lot Calculation:
- Moderna, Inc. a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA (new technology) for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. They are one of the largest suppliers of Covid- 19 vaccine in the world, holding an efficacy rate of more than 90%. More than 800 million doses have been already ordered worldwide.
- EVENT: COVID- 19 VACCINE PATENT PROTECTION: German Chancellor Angela Merkel rejected a U.S. proposal to waive patent protections for coronavirus shots. The World Trade Organization is expected to discuss the matter on Thursday (May 13).
- FIRST QUARTER EARNINGS REPORT: Although Moderna missed Q1 revenue expectations ($1.94 billion vs. $2.22 billion), they, however, managed to lay out some positive things about the company. They managed to beat earnings per share figure ($2.84 vs. $ 2.34 expected). The company raised its product sales projection for 2021 to $19.2 billion from $18.4 billion. Moderna released results of preliminary human trials showing that two types of booster shots helped bolster immune responses against variants that surfaced in South Africa and Brazil.
- EVENT: MODERNA TESTS COVID- 19 VACCINE ON POPULATION BELOW 17 YEARS OF AGE. Initial results from the company’s study of its Covid-19 vaccine in 12-to-17 year old adolescents showed that the vaccine was 96% effective with no serious safety problems. They can be expected soon to ask for the US FDA approval.
- INDIA AND EU TO INCREASE MODERNA COVID-19 VACCINE ORDERS? : The central government in India (1.3 billion of population) announced a change in its policy (April 13). This new policy potentially opens the door for Covid-19 vaccines from Pfizer and Moderna. The European Union, on the other hand, will shortly sign contracts to purchase up to 1.8 billion doses of coronavirus vaccine from Pfizer and Moderna. Japan will decide around May 20 whether to use the Moderna vaccine for mass vaccination.
- PRICE ACTION: Moderna hit a fresh all- time high of $218 in January 2021. At the moment it trades around 25% below its all- time high.
Moderna Inc., (#MODERNA) May 7, 2021
Current Price: 160
|
Moderna Inc. |
Weekly |
|
Trend direction |
|
|
210 |
|
|
200 |
|
|
180 |
|
|
140 |
|
|
130 |
|
|
120 |
Example of calculation base on weekly trend direction for 1.00 Lot*
|
MODERNA INC. |
||||||
|
Pivot Points |
||||||
|
Profit or loss in $ |
50,000.00 |
40,000.00 |
20,000.00 |
-20,000.00 |
-30,000.00 |
-40,000.00 |
|
Profit or loss in €** |
41,394.50 |
33,115.60 |
16,557.80 |
-16,557.80 |
-24,836.70 |
-33,115.60 |
|
Profit or loss in £** |
35,920.31 |
28,736.25 |
14,368.13 |
-14,368.13 |
-21,552.19 |
-28,736.25 |
|
Profit or loss in C$** |
60,916.00 |
48,732.80 |
24,366.40 |
-24,366.40 |
-36,549.60 |
-48,732.80 |
* 1.00 lot is equivalent of 1000 units
** Calculations for exchange rate used as of 9:10 a.m. (GMT+1) 07/05/2021
Fortrade recommends the use of Stop-Loss and Take-Profit, please speak to your Client Manager regarding their use.
*** You may wish to consider closing your position in profit, even if it is lower than suggested one
**** Trailing stop technique can protect the profit – Ask your Client Manager for more details